The EU Commission has issued three new amendments to Regulation (EC) 1907/2006 on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH).
Regulation (EU) 2020/2160 postpones the application and sunset date for the substance group 4-(1,1,3,3-Tetramethylbutyl) phenol, ethoxylated, so it can continue to be used for the diagnosis, treatment or prevention of COVID-19, and in such related medical devices or accessories.
Some changes are also made to Annex 17, which restricts the manufacture, marketing and use of certain substances, mixtures and articles.
Regulation (EU) 2020/2081 adds a new entry for substances in tattoo inks or permanent make-up, and Regulation (EU) 2020/2096 updates and lists new testing methods for azocolorants to replace outdated techniques.
Changes to radiation guidance
A new updated edition of L126 Approved Code of Practice (ACoP) and Guidance for the Radiation (Emergency Preparedness and Public Information) Regulations 2019 (REPPIR) has been published.
This incorporates some changes regarding arrangements for medical surveillance.
An additional threshold equivalent dose has been added of 100mSv to the lens of the eye, and a clarification of any relevant dose limits which is replaced by the dose limits for the skin or extremities.
This guidance also provides supporting good practice advice for operators and local authorities about preparedness and response arrangements for radiation emergencies, in accordance with REPPIR.